Funding agencies: This study was supported by US Army Medical Research and Materiel Command under awards number W81XWH-09-0708 and by Splice Variant Risk Markers for PSP, grant 507-12, from the CurePSP- Foundation for PSP, CBD and Related Brain Diseases (to J.A.P.). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
A network approach to diagnostic biomarkers in progressive supranuclear palsy
Version of Record online: 17 DEC 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 29, Issue 4, pages 550–555, April 2014
How to Cite
Santiago, J. A. and Potashkin, J. A. (2014), A network approach to diagnostic biomarkers in progressive supranuclear palsy. Mov. Disord., 29: 550–555. doi: 10.1002/mds.25761
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 3 APR 2014
- Version of Record online: 17 DEC 2013
- Manuscript Accepted: 1 OCT 2013
- Manuscript Revised: 12 SEP 2013
- Manuscript Received: 23 AUG 2013
Additional Supporting Information may be found in the online version of this article.
|mds25761-sup-0001-supptables.doc||399K||Supplementary Information Table 1 and 2.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.